UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): May 22, 2003
HUMAN PHEROMONE SCIENCES, INC.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
CALIFORNIA 0-23544 94-3107202
- --------------------------------------------------------------------------------
(State or other (Commission File Number) (IRS Employer
jurisdiction of incorporation) Identification No.)
84 W. SANTA CLARA STREET, SUITE 720, SAN JOSE, CALIFORNIA 95113
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (408) 938-3030
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 5. Other Events
Human Pheromone Sciences, Inc. (the "Registrant") today announced that
1,333,333 shares of its Series AA Convertible Redeemable Preferred Stock have
been converted by its holder, MK GVD Fund, into 597,777 shares of Human
Pheromone Sciences, Inc. common stock. In a related transaction, the Company has
redeemed from MK GVD Fund all 17,448 shares of its Series BB Convertible
Redeemable Preferred Stock for $500,000 in cash. At the conclusion of this
transaction, the Company has remaining preferred stock outstanding of 100,000
shares of the Series AA Convertible Redeemable Preferred Stock, currently
convertible into 44,834 shares of Common Stock.
ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Not Applicable.
(b) Not Applicable.
(c) Exhibits
2.1 Purchase Agreement by and between the Registrant and MK Global
Ventures dated as of May 21, 2003.
99.1 Press Release dated June 3, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
HUMAN PHEROMONE SCIENCES, INC.
Date: June 2, 2003 By: /s/ William P. Horgan
-------------------------------------------
William P. Horgan, Chief Executive Officer
EXHIBIT INDEX
2.1 Purchase Agreement by and between the Registrant and MK Global
Ventures dated as of May 21, 2003.
99.1 Press Release dated June 3, 2003.